In November 2020, during the COVID epidemic, monoclonal antibody infusions such as bamlanivimab were identified as an effective treatment for more severe cases of SARS-CoV-2 and were given emergency use authorization (EUA) from the U.S. Food and Drug Administration (FDA, 2020)…
Privacy Policy Update: We value your privacy and want you to understand how your information is being used. To make sure you have current and accurate information about this sites privacy practices please visit the privacy center by clicking here.